FIELD: medicine.
SUBSTANCE: invention belongs to medicine and pharmaceutics, notably to pharmaceutical hepatoprotective composition for oxidative stress reduction and inhibiting of lipid peroxide oxidation reactions and designed for treatment and/or prevention of liver diseases chosen from group, including viral hepatitis A, B, C, D, E and alcoholic hepatitis, it contains therapeutic effective quantities of thioctic (alpha-lipoic) acid, flavonolignans, glycyrrhizic acid or its pharmaceutically acceptable salt and pharmaceutically acceptable carrier, featuring by additional therapeutically active quantity of flacoside, selenium or its pharmaceutically acceptable derivate and acridonacetic acid or its pharmaceutically acceptable salt, and to disease, chosen from group, including viral hepatitis A, B, C, D, E and alcoholic hepatitis , which includes of invented pharmaceutical composition 2-3 times a day.
EFFECT: oxidative stress reduction and inhiting of lipid peroxide oxidation reactions.
20 cl, 1 tbl, 6 ex, 4 dwg
